Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders

Objectives: To assess the differences in comorbid lifetime and current substance use (tobacco, alcohol and drug use) between eating disorder (ED) atients and healthy controls in five different European countries. Method: A total of 1664 participants took part in the present study. ED cases (n = 879)...

Descripción completa

Detalles Bibliográficos
Autores: Krug, Isabel|||0000-0002-5275-3595, Treasure, Janet|||0000-0003-0871-4596, Anderluh, Marija, Bellodi, Laura, Cellini, Elena|||0000-0001-7597-940X, Bernardo, Milena di, Granero, Roser|||0000-0001-6308-3198, Karwautz, Andreas|||0000-0001-9053-998X, Nacmias, Benedetta|||0000-0001-9338-9040, Penelo Werner, Eva|||0000-0001-6796-7660, Ricca, Valdo|||0000-0002-9291-2124, Sorbi, Sandro|||0000-0002-0380-6670, Tchanturia, Kate|||0000-0001-8988-3265, Wagner, Gudrun|||0000-0002-4845-9684, Collier, Davidc, Fernández Aranda, Fernando|||0000-0002-2968-9898
Tipo de recurso: artículo
Fecha de publicación:2008
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:320105
Acceso en línea:https://ddd.uab.cat/record/320105
https://dx.doi.org/urn:doi:10.1016/j.drugalcdep.2008.04.015
Access Level:acceso abierto
Palabra clave:Alcohol use
Cultural differences
Drug use
Eating disorders
Tobacco use
Descripción
Sumario:Objectives: To assess the differences in comorbid lifetime and current substance use (tobacco, alcohol and drug use) between eating disorder (ED) atients and healthy controls in five different European countries. Method: A total of 1664 participants took part in the present study. ED cases (n = 879) were referred to specialized ED units in five European countries. The ED cases were compared to a balanced control group of 785 healthy individuals. Assessment: Participants completed the Substance Use Subscale of the Cross Cultural (Environmental) Questionnaire (CCQ), a measure of lifetime tobacco, alcohol and drug use. In the control group, also the GHQ-28, the SCID-I interview and the EAT-26 were used. Results: ED patients had higher lifetime and current tobacco and general drug use. The only non-significant result was obtained for lifetime and current alcohol use. Significant differences across ED subdiagnoses and controls also emerged, with BN and AN-BP generally presenting the highest and AN-R and controls the lowest rates. The only exception was detected for alcohol use where EDNOS demonstrated the highest values. Only a few cultural differences between countries emerged. Conclusions: With the exception of alcohol consumption, tobacco and drug use appear to be more prevalent in ED patients than healthy controls. he differential risk observed in patients with bulimic features might be related to differences in temperament or might be the result of increased sensitivity to reward.

Similares en LA Referencia